Safety of an SV-1 Cell Line-Based Varicella Vaccine Before and After Integration into the Expanded Program on Immunization: A Real-World Study in Jiangsu Province, China.

Vaccines (Basel) · 2026 · PMC13030554 · PMID 41893737

Europe PMC DOI

hedged sentence

0.1820

closest p · 3.6× alpha

0.1820

boldest claim

The sentences

did not reach statistical significancep = 0.182not close (p > 0.1)

Although a higher reporting rate was observed in 2023 compared with 2021 (RR = 1.40, 95% CI: 0.88–2.38), this difference did not reach statistical significance ( p = 0.182).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.